24/05/2024  16:54:25 Chg. - Volume Bid17:40:03 Demandez à17:40:03 Capitalisation boursière Dividende Y. Rapport P/E
40.73CHF - 637
Chiffrre d'affaires: 23,400.11
-Bid taille: - -Ask la taille: - 2.07 Mrd.CHF 5.34% -

Description de l'entreprise

BB Biotech invests in companies in the fast growing market of biotechnology and is one of the world’s largest investors in this sector. BB Biotech is listed in Switzerland, Germany and Italy. Its investments are focused on listed companies that are developing and commercializing novel medical treatments and cures. BB Biotech’s investment selection process is guided by the fundamental research and analysis of physicians and molecular biologists. Its Board of Directors has many years of experience in industry and science.
 

Conseil d'administration & Conseil de surveillance

PDG
-
Conseil d'administration
-
Conseil de surveillance
Dr. Thomas von Planta, Dr. Clive Meanwell, Laura Hamill, Dr. Pearl Huang, Camilla Soenderby, Prof. Dr. Mads Krogsgaard Thomsen
 

Données de l'entreprise

Nom: BB Biotech AG
Adresse: Schwertstraße 6,CH-8200 Schaffhausen/Schweiz
Téléphone: +41-52-624-0845
Fax: -
Courriel: info@bbbiotech.com
Internet: www.bbbiotech.com
Industrie: Financial
Secteur: Specialty Finance
Sous-secteur: Diversified Financial
Fin de l'exercice financier: 31/12
Flotte libre: 100.00%
IPO date: 10/12/1997

Relations avec les investisseurs

Nom: Dr. Silvia Siegfried-Schanz
Téléphone IR: +41-44-267-7266
IR-Fax: -
E-mail IR: ssc@bellevue.ch

Principaux actionnaires

FreeFloat
 
96.47%
Lazard Asset Management LLC, New York, USA
 
3.53%